Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer

Clinical Cancer Research

Volumn 8, Issue 2, 2002, Pages 620-627

  Maulik, Gautam ^a   Kijima, Takashi ^a   Ma, Patrick C ^a   Ghosh, Sudip K ^d   Lin, Jeffrey ^a   Shapiro, Geoffrey I ^a   Schaefer, Erik ^c   Tibaldi, Elena ^a,b   Johnson, Bruce E ^a   Salgia, Ravi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Biosource International   (United States)

^d INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; FOCAL ADHESION KINASE 2; GELDANAMYCIN; GLYCOPROTEIN P; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; PAXILLIN; PROTEIN; PROTEIN FAK; PROTEIN P140; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; AUTOPHOSPHORYLATION; CANCER INVASION; CELL GROWTH; CELL MEMBRANE; CELL MOTILITY; CONTROLLED STUDY; FILOPODIUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BENZOQUINONES; CARCINOMA, SMALL CELL; CELL CYCLE; CELL MOVEMENT; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOBLOTTING; LACTAMS, MACROCYCLIC; LUNG NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; QUINONES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0036188465     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: Perceptible progress
2. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia
3. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
4. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts
5. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers
6. Evidence for non-covalent clusters of the c-met proto-oncogene product
7. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene
8. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor
9. HGF: A multifunctional growth factor controlling cell scattering
10. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene
11. The clinical significance of hepatocyte growth factor for non-small cell lung cancer
12. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility
13. Thrombopoietin induces activation of the phosphatidylinositol-3′ kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL
14. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network
15. The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells
16. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL)
17. Hematopoietic growth factors signal through the formation of reactive oxygen species
18. The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1α
19. Geldanamycin as a potential anti-cancer agent: Its molecular target and biochemical activity
20. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
21. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase
22. Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell motility and tubulogenesis
23. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
24. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
25. Rho GTPases control polarity, protrusion, and adhesion during cell movement
26. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells
27. Role of the cytoskeletal protein paxillin in oncogenesis
28. Rho, fac and cdc42 GTPases: Regulators of actin structures, cell adhesion and motility
29. Activation of the small GTP-binding proteins rho and fac by growth factor receptors
30. Role of redox potential and reactive oxygen species in stress signaling
31. Redox regulation of cellular signaling
32. Role of oxidants/antioxidants in smoking-induced lung diseases
33. Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor
34. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome
35. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations